Sildenafil Tablet
Product Images NDC 27241-124

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 27241-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil 20mg

Label for Sildenafil Tablets, USP 20 mg by Ajanta Pharma USA Inc. The label includes dosage information, storage instructions, a note on child resistance, bar code, and marketing details stating the product is made in India and marketed by Ajanta Pharma USA Inc. The label also shows the product NDC 27241-124-03 and indicates a package count of 90 tablets.*

FDA Label Image

Figure1 (Sildenafil Figure 1)

A Kaplan-Meier survival curve chart showing estimated cumulative mortality rate (%) over time in years. The chart compares three groups based on dose levels labeled as High Dose, Medium Dose, and Low Dose, with mortality rates increasing over a 5-year period. The number at risk is shown at various time points for each group.*

FDA Label Image

Sildenafil_fig2 (Sildenafil Figure 2)

A forest plot chart showing fold change and 90% confidence intervals of sildenafil pharmacokinetics (AUC and Cmax) when coadministered with various interacting drugs. The chart includes drugs such as Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir, along with corresponding recommendations on dose adjustment or coadministration advisories.*

FDA Label Image

Figure3 (Sildenafil Figure 3)

A chart showing fold change and 90% confidence intervals for various interacting drugs with labeled metrics such as INR, AUC, Cmax, and BT. Each drug is listed with corresponding fold change markers on a horizontal scale from 0.5 to 2, along with dosing recommendations indicating mostly no dose adjustment except for Ritonavir where coadministration is not recommended.*

FDA Label Image

Figure4 (Sildenafil Figure 4)

A line graph showing the change from baseline in meters on the vertical axis over Weeks 4, 8, and 12 on the horizontal axis. The graph compares four groups: Placebo, Sildenafil 20 mg TID, Sildenafil 40 mg TID, and Sildenafil 80 mg TID, with data points and error bars illustrating treatment response trends over the study period.*

FDA Label Image

Figure5 (Sildenafil Figure 5)

A forest plot showing placebo-corrected change in 6-minute walk distance (meters) for Sildenafil 20 mg TID across various subgroups. The subgroups include baseline walk distance, etiology, PH criteria for functional capacity, gender, age, mean PAP, and PVRI. Data points are represented by diamonds with horizontal lines indicating confidence intervals, comparing placebo versus sildenafil effects.*

FDA Label Image

Figure6 (Sildenafil Figure 6)

A Kaplan-Meier survival curve chart showing the percentage of subjects without a clinically worsening event over days from randomization (0 to 112). Two groups are compared: placebo (solid line) and Sildenafil (dashed line), with the Sildenafil group maintaining a higher percentage over time than placebo.*

FDA Label Image

Sildenafil-figure-7 (Sildenafil Figure 7)

A line plot showing mean change from baseline in meters with standard error bars over 12 weeks of study for Sildenafil tablets at doses of 1 mg, 5 mg, and 20 mg taken three times daily (TID). The x-axis represents weeks 4, 8, and 12, and the y-axis shows change from baseline in meters. The plot compares the three dosages' efficacy trends over time.*

FDA Label Image

Structure (Sildenafil Structure)

Chemical structure of Sildenafil, illustrating its molecular framework with distinct functional groups and heterocyclic rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.